Class II · Moderate risk
Calcium Gluconate 1% Eyewash Oph. Soln
Lack of Assurance of Sterility
FDA Drug Recalls
11,818 recalls · Class II, newest first
Class II · Moderate risk
Caffeine and Sodium Benzoate Injection 125 mg/125 mg/mL Injectable Pharm D Solutions
Lack of Assurance of Sterility
Class II · Moderate risk
Bi-Mix (Papaverine/Phentolamine 150 mg/5 mg)
Lack of Assurance of Sterility
Class II · Moderate risk
Bi-Mix Injection
Lack of Assurance of Sterility
Class II · Moderate risk
Bi-Mix Injection
Lack of Assurance of Sterility
Class II · Moderate risk
Bi-Mix Injection
Lack of Assurance of Sterility
Class II · Moderate risk
Bacteriostatic Water for Injection 10 mL
Lack of Assurance of Sterility
Class II · Moderate risk
Beta-complex B-1
Lack of Assurance of Sterility
Class II · Moderate risk
Ascorbic Acid 500 mg/mL Solution Pharm D Solutions
Lack of Assurance of Sterility
Class II · Moderate risk
Arginine Injections 100 mcg/mL
Lack of Assurance of Sterility
Class II · Moderate risk
Acetylcysteine Injection 10 mg/5 mL
Lack of Assurance of Sterility
Class II · Moderate risk
Actoplus met XR
Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.
Class II · Moderate risk
Minivelle (estradiol transdermal system)
Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.
Class II · Moderate risk
Minivelle (estradiol transdermal system)
Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.
Class II · Moderate risk
Minivelle (estradiol transdermal system)
Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.
Class II · Moderate risk
Minivelle (estradiol transdermal system)
Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.
Class II · Moderate risk
Class II · Moderate risk
Synjardy (empagliflozin and metformin hydrochloride)
Cross Contamination With Other Products:
Class II · Moderate risk
Tizanidine HCl Tablets
Presence of Foreign Tablets/Capsules: Glimepiride tablet was found in a bottle of Tinzadine Hcl Tablets .
Class II · Moderate risk
Arthritis Pain Relief Homeopathic Formula
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
Class II · Moderate risk
Colds & Flu Response Homeopathic Formula
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
Class II · Moderate risk
Allergy & Hay Fever Relief Homeopathic Formula
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
Class II · Moderate risk
Muscle & Joint Pain Relief Homeopathic Formula
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
Class II · Moderate risk
Diarrhea Response Homeopathic Formula
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
Class II · Moderate risk
Sore Throat & Laryngitis Response Homeopathic Formula
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.